P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS

• Priyanka Mehta,
• Victoria Campbell,
• Jamie Maddox,
• Yngvar Floisand,
• Jenny O’nions,
• Joe Cross,
• Thomas Coats,
• Mark Lynam,
• Montse Roset,
• Greg Medalla,
• Saemi Park,
• Hayley Kuter,
• Alex Legg,
• Anjum Khan

Affiliations

Priyanka Mehta

1 University Hospitals of Bristol and Weston NHS Trust, Bristol, United Kingdom

Victoria Campbell

2 Western General Hospital, Edinburgh, United Kingdom

Jamie Maddox

3 South Tees Hospitals NHS Foundation Trust, Middlesborough, United Kingdom

Yngvar Floisand

4 Clatterbridge Cancer Centre, NHS Foundation Trust, Liverpool, United Kingdom

Jenny O’nions

5 University College London Hospitals, NHS Foundation Trust, London, United Kingdom

Joe Cross

1 University Hospitals of Bristol and Weston NHS Trust, Bristol, United Kingdom

Thomas Coats

6 Royal Devon University Healthcare, NHS Foundation Trust, Exeter, United Kingdom

Mark Lynam

7 IQVIA, Real World Solutions, Barcelona, Spain

Montse Roset

7 IQVIA, Real World Solutions, Barcelona, Spain

Greg Medalla

8 Jazz Pharmaceuticals, Oxford, United Kingdom

Saemi Park

8 Jazz Pharmaceuticals, Oxford, United Kingdom

Hayley Kuter

8 Jazz Pharmaceuticals, Oxford, United Kingdom

Alex Legg

8 Jazz Pharmaceuticals, Oxford, United Kingdom

Anjum Khan

9 Leeds Teaching Hospitals, NHS Foundation Trust, Leeds, United Kingdom